Table 1 Baseline clinical and laboratory characteristics of type 2 diabetic patients included in the study
From: Are diabetes management guidelines applicable in ‘real life’?
Baseline | |
|---|---|
N | 90 |
Age (years) | 62.7 ± 10.4 |
White ethnicity | 71 (78.9%) |
Women | 52 (57.8%) |
Diabetes duration (years) | 8.2 ± 9.1 |
Primary care unit attendance (years) | 2.1 ± 2.5 |
Previous cardiovascular event | 21 (23.3%) |
Current Smoking | 13 (14.4%) |
Hypertension | 79 (89.8%) |
SBP (mmHg) | 144.3 ± 22.7 |
DBP (mmHg) | 79.4 ± 10.7 |
BMI (kg/m2) | 29.8 ± 4.9 |
Using statin | 45 (50%) |
Using aspirin | 55 (61.1%) |
Microalbuminuria | 20 (23.8%) |
Treatment Type | |
Diet only | 10 (11.1%) |
One oral agent | 33 (36.6%) |
Metformin | 30 |
Glybenclamide | 3 |
Two oral agents | 28 (31.1%) |
Insulin use | 19 (21.1%) |
NPH alone | 4 |
NPH + Metformin | 14 |
NPH + Glybenclamide | 0 |
NPH + Metformin + Glybenclamide | 1 |
Total cholesterol (mg/dl) | 179.1 ± 41.2 |
HDL cholesterol (mg/dl) | 47.5 ± 11.8 |
Triglycerides (mg/dl) | 153 (109.0 -216.5) |
LDL cholesterol (mg/dl) | 94.9 ± 33.0 |
Creatinine (mg/dl) | 0.86± 0.24 |
HbA1c (%) | 7.2 ± 1.6 |